Global Vaccine Vial Market Insights And Forecast To 2028

1 Study Coverage
1.1 Vaccine Vial Product Introduction
1.2 Market by Type
1.2.1 Global Vaccine Vial Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Single Dose
1.2.3 Multi-dose
1.3 Market by Application
1.3.1 Global Vaccine Vial Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Preventive Vaccine
1.3.3 Therapeutic Vaccine
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vaccine Vial Sales Estimates and Forecasts 2017-2028
2.2 Global Vaccine Vial Revenue Estimates and Forecasts 2017-2028
2.3 Global Vaccine Vial Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Vaccine Vial Sales by Region
2.4.1 Global Vaccine Vial Sales by Region (2017-2022)
2.4.2 Global Sales Vaccine Vial by Region (2023-2028)
2.5 Global Vaccine Vial Revenue by Region
2.5.1 Global Vaccine Vial Revenue by Region (2017-2022)
2.5.2 Global Vaccine Vial Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Vaccine Vial Sales by Manufacturers
3.1.1 Global Top Vaccine Vial Manufacturers by Sales (2017-2022)
3.1.2 Global Vaccine Vial Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccine Vial in 2021
3.2 Global Vaccine Vial Revenue by Manufacturers
3.2.1 Global Vaccine Vial Revenue by Manufacturers (2017-2022)
3.2.2 Global Vaccine Vial Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Vaccine Vial Revenue in 2021
3.3 Global Vaccine Vial Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Vaccine Vial Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Vaccine Vial Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vaccine Vial Sales by Type
4.1.1 Global Vaccine Vial Historical Sales by Type (2017-2022)
4.1.2 Global Vaccine Vial Forecasted Sales by Type (2023-2028)
4.1.3 Global Vaccine Vial Sales Market Share by Type (2017-2028)
4.2 Global Vaccine Vial Revenue by Type
4.2.1 Global Vaccine Vial Historical Revenue by Type (2017-2022)
4.2.2 Global Vaccine Vial Forecasted Revenue by Type (2023-2028)
4.2.3 Global Vaccine Vial Revenue Market Share by Type (2017-2028)
4.3 Global Vaccine Vial Price by Type
4.3.1 Global Vaccine Vial Price by Type (2017-2022)
4.3.2 Global Vaccine Vial Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Vaccine Vial Sales by Application
5.1.1 Global Vaccine Vial Historical Sales by Application (2017-2022)
5.1.2 Global Vaccine Vial Forecasted Sales by Application (2023-2028)
5.1.3 Global Vaccine Vial Sales Market Share by Application (2017-2028)
5.2 Global Vaccine Vial Revenue by Application
5.2.1 Global Vaccine Vial Historical Revenue by Application (2017-2022)
5.2.2 Global Vaccine Vial Forecasted Revenue by Application (2023-2028)
5.2.3 Global Vaccine Vial Revenue Market Share by Application (2017-2028)
5.3 Global Vaccine Vial Price by Application
5.3.1 Global Vaccine Vial Price by Application (2017-2022)
5.3.2 Global Vaccine Vial Price Forecast by Application (2023-2028)
6 North America
6.1 North America Vaccine Vial Market Size by Type
6.1.1 North America Vaccine Vial Sales by Type (2017-2028)
6.1.2 North America Vaccine Vial Revenue by Type (2017-2028)
6.2 North America Vaccine Vial Market Size by Application
6.2.1 North America Vaccine Vial Sales by Application (2017-2028)
6.2.2 North America Vaccine Vial Revenue by Application (2017-2028)
6.3 North America Vaccine Vial Market Size by Country
6.3.1 North America Vaccine Vial Sales by Country (2017-2028)
6.3.2 North America Vaccine Vial Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Vaccine Vial Market Size by Type
7.1.1 Europe Vaccine Vial Sales by Type (2017-2028)
7.1.2 Europe Vaccine Vial Revenue by Type (2017-2028)
7.2 Europe Vaccine Vial Market Size by Application
7.2.1 Europe Vaccine Vial Sales by Application (2017-2028)
7.2.2 Europe Vaccine Vial Revenue by Application (2017-2028)
7.3 Europe Vaccine Vial Market Size by Country
7.3.1 Europe Vaccine Vial Sales by Country (2017-2028)
7.3.2 Europe Vaccine Vial Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vaccine Vial Market Size by Type
8.1.1 Asia Pacific Vaccine Vial Sales by Type (2017-2028)
8.1.2 Asia Pacific Vaccine Vial Revenue by Type (2017-2028)
8.2 Asia Pacific Vaccine Vial Market Size by Application
8.2.1 Asia Pacific Vaccine Vial Sales by Application (2017-2028)
8.2.2 Asia Pacific Vaccine Vial Revenue by Application (2017-2028)
8.3 Asia Pacific Vaccine Vial Market Size by Region
8.3.1 Asia Pacific Vaccine Vial Sales by Region (2017-2028)
8.3.2 Asia Pacific Vaccine Vial Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Vaccine Vial Market Size by Type
9.1.1 Latin America Vaccine Vial Sales by Type (2017-2028)
9.1.2 Latin America Vaccine Vial Revenue by Type (2017-2028)
9.2 Latin America Vaccine Vial Market Size by Application
9.2.1 Latin America Vaccine Vial Sales by Application (2017-2028)
9.2.2 Latin America Vaccine Vial Revenue by Application (2017-2028)
9.3 Latin America Vaccine Vial Market Size by Country
9.3.1 Latin America Vaccine Vial Sales by Country (2017-2028)
9.3.2 Latin America Vaccine Vial Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vaccine Vial Market Size by Type
10.1.1 Middle East and Africa Vaccine Vial Sales by Type (2017-2028)
10.1.2 Middle East and Africa Vaccine Vial Revenue by Type (2017-2028)
10.2 Middle East and Africa Vaccine Vial Market Size by Application
10.2.1 Middle East and Africa Vaccine Vial Sales by Application (2017-2028)
10.2.2 Middle East and Africa Vaccine Vial Revenue by Application (2017-2028)
10.3 Middle East and Africa Vaccine Vial Market Size by Country
10.3.1 Middle East and Africa Vaccine Vial Sales by Country (2017-2028)
10.3.2 Middle East and Africa Vaccine Vial Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Schott
11.1.1 Schott Corporation Information
11.1.2 Schott Overview
11.1.3 Schott Vaccine Vial Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Schott Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Schott Recent Developments
11.2 Nippon Electric Glass
11.2.1 Nippon Electric Glass Corporation Information
11.2.2 Nippon Electric Glass Overview
11.2.3 Nippon Electric Glass Vaccine Vial Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Nippon Electric Glass Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Nippon Electric Glass Recent Developments
11.3 Corning
11.3.1 Corning Corporation Information
11.3.2 Corning Overview
11.3.3 Corning Vaccine Vial Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Corning Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Corning Recent Developments
11.4 DWK Life Sciences
11.4.1 DWK Life Sciences Corporation Information
11.4.2 DWK Life Sciences Overview
11.4.3 DWK Life Sciences Vaccine Vial Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 DWK Life Sciences Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 DWK Life Sciences Recent Developments
11.5 Richland Glass
11.5.1 Richland Glass Corporation Information
11.5.2 Richland Glass Overview
11.5.3 Richland Glass Vaccine Vial Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Richland Glass Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Richland Glass Recent Developments
11.6 Nipro
11.6.1 Nipro Corporation Information
11.6.2 Nipro Overview
11.6.3 Nipro Vaccine Vial Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Nipro Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Nipro Recent Developments
11.7 Pacific Vial Manufacturing
11.7.1 Pacific Vial Manufacturing Corporation Information
11.7.2 Pacific Vial Manufacturing Overview
11.7.3 Pacific Vial Manufacturing Vaccine Vial Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Pacific Vial Manufacturing Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pacific Vial Manufacturing Recent Developments
11.8 Origin Ltd
11.8.1 Origin Ltd Corporation Information
11.8.2 Origin Ltd Overview
11.8.3 Origin Ltd Vaccine Vial Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Origin Ltd Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Origin Ltd Recent Developments
11.9 Stevanato Group
11.9.1 Stevanato Group Corporation Information
11.9.2 Stevanato Group Overview
11.9.3 Stevanato Group Vaccine Vial Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Stevanato Group Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Stevanato Group Recent Developments
11.10 SGD Pharma
11.10.1 SGD Pharma Corporation Information
11.10.2 SGD Pharma Overview
11.10.3 SGD Pharma Vaccine Vial Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 SGD Pharma Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 SGD Pharma Recent Developments
11.11 Piramal Glass
11.11.1 Piramal Glass Corporation Information
11.11.2 Piramal Glass Overview
11.11.3 Piramal Glass Vaccine Vial Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Piramal Glass Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Piramal Glass Recent Developments
11.12 Zheng Chuan
11.12.1 Zheng Chuan Corporation Information
11.12.2 Zheng Chuan Overview
11.12.3 Zheng Chuan Vaccine Vial Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Zheng Chuan Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Zheng Chuan Recent Developments
11.13 Shandong Pharmaceutical Glass
11.13.1 Shandong Pharmaceutical Glass Corporation Information
11.13.2 Shandong Pharmaceutical Glass Overview
11.13.3 Shandong Pharmaceutical Glass Vaccine Vial Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Shandong Pharmaceutical Glass Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Shandong Pharmaceutical Glass Recent Developments
11.14 Gerresheimer
11.14.1 Gerresheimer Corporation Information
11.14.2 Gerresheimer Overview
11.14.3 Gerresheimer Vaccine Vial Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Gerresheimer Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Gerresheimer Recent Developments
11.15 Four Stars Glass
11.15.1 Four Stars Glass Corporation Information
11.15.2 Four Stars Glass Overview
11.15.3 Four Stars Glass Vaccine Vial Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Four Stars Glass Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Four Stars Glass Recent Developments
11.16 JOTOP Glass
11.16.1 JOTOP Glass Corporation Information
11.16.2 JOTOP Glass Overview
11.16.3 JOTOP Glass Vaccine Vial Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 JOTOP Glass Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 JOTOP Glass Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vaccine Vial Industry Chain Analysis
12.2 Vaccine Vial Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vaccine Vial Production Mode & Process
12.4 Vaccine Vial Sales and Marketing
12.4.1 Vaccine Vial Sales Channels
12.4.2 Vaccine Vial Distributors
12.5 Vaccine Vial Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Vaccine Vial Industry Trends
13.2 Vaccine Vial Market Drivers
13.3 Vaccine Vial Market Challenges
13.4 Vaccine Vial Market Restraints
14 Key Findings in The Global Vaccine Vial Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Vaccine Vial Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Single Dose
Table 3. Major Manufacturers of Multi-dose
Table 4. Global Vaccine Vial Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Vaccine Vial Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Vaccine Vial Sales by Region (2017-2022) & (K Units)
Table 7. Global Vaccine Vial Sales Market Share by Region (2017-2022)
Table 8. Global Vaccine Vial Sales by Region (2023-2028) & (K Units)
Table 9. Global Vaccine Vial Sales Market Share by Region (2023-2028)
Table 10. Global Vaccine Vial Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Vaccine Vial Revenue Market Share by Region (2017-2022)
Table 12. Global Vaccine Vial Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Vaccine Vial Revenue Market Share by Region (2023-2028)
Table 14. Global Vaccine Vial Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Vaccine Vial Sales Share by Manufacturers (2017-2022)
Table 16. Global Vaccine Vial Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Vaccine Vial Revenue Share by Manufacturers (2017-2022)
Table 18. Vaccine Vial Price by Manufacturers (2017-2022) &(US$/K Units)
Table 19. Global Vaccine Vial Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Vaccine Vial by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Vial as of 2021)
Table 21. Vaccine Vial Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Vaccine Vial Product Offered
Table 23. Date of Manufacturers Enter into Vaccine Vial Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Vaccine Vial Sales by Type (2017-2022) & (K Units)
Table 26. Global Vaccine Vial Sales by Type (2023-2028) & (K Units)
Table 27. Global Vaccine Vial Sales Share by Type (2017-2022)
Table 28. Global Vaccine Vial Sales Share by Type (2023-2028)
Table 29. Global Vaccine Vial Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Vaccine Vial Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Vaccine Vial Revenue Share by Type (2017-2022)
Table 32. Global Vaccine Vial Revenue Share by Type (2023-2028)
Table 33. Vaccine Vial Price by Type (2017-2022) & (US$/K Units)
Table 34. Global Vaccine Vial Price Forecast by Type (2023-2028) & (US$/K Units)
Table 35. Global Vaccine Vial Sales by Application (2017-2022) & (K Units)
Table 36. Global Vaccine Vial Sales by Application (2023-2028) & (K Units)
Table 37. Global Vaccine Vial Sales Share by Application (2017-2022)
Table 38. Global Vaccine Vial Sales Share by Application (2023-2028)
Table 39. Global Vaccine Vial Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Vaccine Vial Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Vaccine Vial Revenue Share by Application (2017-2022)
Table 42. Global Vaccine Vial Revenue Share by Application (2023-2028)
Table 43. Vaccine Vial Price by Application (2017-2022) & (US$/K Units)
Table 44. Global Vaccine Vial Price Forecast by Application (2023-2028) & (US$/K Units)
Table 45. North America Vaccine Vial Sales by Type (2017-2022) & (K Units)
Table 46. North America Vaccine Vial Sales by Type (2023-2028) & (K Units)
Table 47. North America Vaccine Vial Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Vaccine Vial Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Vaccine Vial Sales by Application (2017-2022) & (K Units)
Table 50. North America Vaccine Vial Sales by Application (2023-2028) & (K Units)
Table 51. North America Vaccine Vial Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Vaccine Vial Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Vaccine Vial Sales by Country (2017-2022) & (K Units)
Table 54. North America Vaccine Vial Sales by Country (2023-2028) & (K Units)
Table 55. North America Vaccine Vial Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Vaccine Vial Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Vaccine Vial Sales by Type (2017-2022) & (K Units)
Table 58. Europe Vaccine Vial Sales by Type (2023-2028) & (K Units)
Table 59. Europe Vaccine Vial Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Vaccine Vial Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Vaccine Vial Sales by Application (2017-2022) & (K Units)
Table 62. Europe Vaccine Vial Sales by Application (2023-2028) & (K Units)
Table 63. Europe Vaccine Vial Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Vaccine Vial Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Vaccine Vial Sales by Country (2017-2022) & (K Units)
Table 66. Europe Vaccine Vial Sales by Country (2023-2028) & (K Units)
Table 67. Europe Vaccine Vial Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Vaccine Vial Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Vaccine Vial Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Vaccine Vial Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Vaccine Vial Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Vaccine Vial Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Vaccine Vial Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Vaccine Vial Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Vaccine Vial Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Vaccine Vial Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Vaccine Vial Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Vaccine Vial Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Vaccine Vial Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Vaccine Vial Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Vaccine Vial Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Vaccine Vial Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Vaccine Vial Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Vaccine Vial Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Vaccine Vial Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Vaccine Vial Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Vaccine Vial Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Vaccine Vial Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Vaccine Vial Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Vaccine Vial Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Vaccine Vial Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Vaccine Vial Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Vaccine Vial Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Vaccine Vial Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Vaccine Vial Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Vaccine Vial Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Vaccine Vial Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Vaccine Vial Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Vaccine Vial Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Vaccine Vial Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Vaccine Vial Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Vaccine Vial Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Vaccine Vial Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Vaccine Vial Revenue by Country (2023-2028) & (US$ Million)
Table 105. Schott Corporation Information
Table 106. Schott Description and Major Businesses
Table 107. Schott Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 108. Schott Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Schott Recent Developments
Table 110. Nippon Electric Glass Corporation Information
Table 111. Nippon Electric Glass Description and Major Businesses
Table 112. Nippon Electric Glass Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 113. Nippon Electric Glass Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Nippon Electric Glass Recent Developments
Table 115. Corning Corporation Information
Table 116. Corning Description and Major Businesses
Table 117. Corning Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 118. Corning Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Corning Recent Developments
Table 120. DWK Life Sciences Corporation Information
Table 121. DWK Life Sciences Description and Major Businesses
Table 122. DWK Life Sciences Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 123. DWK Life Sciences Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. DWK Life Sciences Recent Developments
Table 125. Richland Glass Corporation Information
Table 126. Richland Glass Description and Major Businesses
Table 127. Richland Glass Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 128. Richland Glass Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Richland Glass Recent Developments
Table 130. Nipro Corporation Information
Table 131. Nipro Description and Major Businesses
Table 132. Nipro Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 133. Nipro Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Nipro Recent Developments
Table 135. Pacific Vial Manufacturing Corporation Information
Table 136. Pacific Vial Manufacturing Description and Major Businesses
Table 137. Pacific Vial Manufacturing Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 138. Pacific Vial Manufacturing Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Pacific Vial Manufacturing Recent Developments
Table 140. Origin Ltd Corporation Information
Table 141. Origin Ltd Description and Major Businesses
Table 142. Origin Ltd Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 143. Origin Ltd Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Origin Ltd Recent Developments
Table 145. Stevanato Group Corporation Information
Table 146. Stevanato Group Description and Major Businesses
Table 147. Stevanato Group Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 148. Stevanato Group Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Stevanato Group Recent Developments
Table 150. SGD Pharma Corporation Information
Table 151. SGD Pharma Description and Major Businesses
Table 152. SGD Pharma Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 153. SGD Pharma Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. SGD Pharma Recent Developments
Table 155. Piramal Glass Corporation Information
Table 156. Piramal Glass Description and Major Businesses
Table 157. Piramal Glass Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 158. Piramal Glass Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Piramal Glass Recent Developments
Table 160. Zheng Chuan Corporation Information
Table 161. Zheng Chuan Description and Major Businesses
Table 162. Zheng Chuan Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 163. Zheng Chuan Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Zheng Chuan Recent Developments
Table 165. Shandong Pharmaceutical Glass Corporation Information
Table 166. Shandong Pharmaceutical Glass Description and Major Businesses
Table 167. Shandong Pharmaceutical Glass Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 168. Shandong Pharmaceutical Glass Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Shandong Pharmaceutical Glass Recent Developments
Table 170. Gerresheimer Corporation Information
Table 171. Gerresheimer Description and Major Businesses
Table 172. Gerresheimer Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 173. Gerresheimer Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Gerresheimer Recent Developments
Table 175. Four Stars Glass Corporation Information
Table 176. Four Stars Glass Description and Major Businesses
Table 177. Four Stars Glass Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 178. Four Stars Glass Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Four Stars Glass Recent Developments
Table 180. JOTOP Glass Corporation Information
Table 181. JOTOP Glass Description and Major Businesses
Table 182. JOTOP Glass Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 183. JOTOP Glass Vaccine Vial Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. JOTOP Glass Recent Developments
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Vaccine Vial Distributors List
Table 188. Vaccine Vial Customers List
Table 189. Vaccine Vial Market Trends
Table 190. Vaccine Vial Market Drivers
Table 191. Vaccine Vial Market Challenges
Table 192. Vaccine Vial Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccine Vial Product Picture
Figure 3. Global Vaccine Vial Market Share by Type in 2021 & 2028
Figure 3. Single Dose Product Picture
Figure 4. Multi-dose Product Picture
Figure 5. Global Vaccine Vial Market Share by Application in 2021 & 2028
Figure 6. Preventive Vaccine
Figure 7. Therapeutic Vaccine
Figure 8. Vaccine Vial Report Years Considered
Figure 9. Global Vaccine Vial Sales 2017-2028 (K Units)
Figure 10. Global Vaccine Vial Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Vaccine Vial Revenue 2017-2028 (US$ Million)
Figure 12. Global Vaccine Vial Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Vaccine Vial Sales Market Share by Region (2017-2022)
Figure 14. Global Vaccine Vial Sales Market Share by Region (2023-2028)
Figure 15. North America Vaccine Vial Sales YoY (2017-2028) & (K Units)
Figure 16. North America Vaccine Vial Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Vaccine Vial Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Vaccine Vial Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Vaccine Vial Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Vaccine Vial Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Vaccine Vial Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Vaccine Vial Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Vaccine Vial Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Vaccine Vial Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Vaccine Vial Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Vaccine Vial in the World: Market Share by Vaccine Vial Revenue in 2021
Figure 27. Global Vaccine Vial Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Vaccine Vial Sales Market Share by Type (2017-2028)
Figure 29. Global Vaccine Vial Revenue Market Share by Type (2017-2028)
Figure 30. Global Vaccine Vial Sales Market Share by Application (2017-2028)
Figure 31. Global Vaccine Vial Revenue Market Share by Application (2017-2028)
Figure 32. North America Vaccine Vial Sales Market Share by Type (2017-2028)
Figure 33. North America Vaccine Vial Revenue Market Share by Type (2017-2028)
Figure 34. North America Vaccine Vial Sales Market Share by Application (2017-2028)
Figure 35. North America Vaccine Vial Revenue Market Share by Application (2017-2028)
Figure 36. North America Vaccine Vial Sales Share by Country (2017-2028)
Figure 37. North America Vaccine Vial Revenue Share by Country (2017-2028)
Figure 38. U.S. Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Vaccine Vial Sales Market Share by Type (2017-2028)
Figure 41. Europe Vaccine Vial Revenue Market Share by Type (2017-2028)
Figure 42. Europe Vaccine Vial Sales Market Share by Application (2017-2028)
Figure 43. Europe Vaccine Vial Revenue Market Share by Application (2017-2028)
Figure 44. Europe Vaccine Vial Sales Share by Country (2017-2028)
Figure 45. Europe Vaccine Vial Revenue Share by Country (2017-2028)
Figure 46. Germany Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 47. France Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Vaccine Vial Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Vaccine Vial Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Vaccine Vial Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Vaccine Vial Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Vaccine Vial Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Vaccine Vial Revenue Share by Region (2017-2028)
Figure 57. China Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 60. India Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 62. Taiwan Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 66. Philippines Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Vaccine Vial Sales Market Share by Type (2017-2028)
Figure 68. Latin America Vaccine Vial Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Vaccine Vial Sales Market Share by Application (2017-2028)
Figure 70. Latin America Vaccine Vial Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Vaccine Vial Sales Share by Country (2017-2028)
Figure 72. Latin America Vaccine Vial Revenue Share by Country (2017-2028)
Figure 73. Mexico Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Vaccine Vial Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Vaccine Vial Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Vaccine Vial Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Vaccine Vial Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Vaccine Vial Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Vaccine Vial Revenue Share by Country (2017-2028)
Figure 82. Turkey Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Vaccine Vial Revenue (2017-2028) & (US$ Million)
Figure 85. Vaccine Vial Value Chain
Figure 86. Vaccine Vial Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.